Allosteric Binding Site in a Cys-Loop Receptor Ligand-Binding Domain

Total Page:16

File Type:pdf, Size:1020Kb

Allosteric Binding Site in a Cys-Loop Receptor Ligand-Binding Domain Allosteric binding site in a Cys-loop receptor PNAS PLUS ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine Mieke Nysa, Eveline Wijckmansa, Ana Farinhaa, Özge Yolukb,c, Magnus Anderssonb,c, Marijke Bramsa, Radovan Spurnya,1, Steve Peigneurd, Jan Tytgatd, Erik Lindahlb,c,e, and Chris Ulensa,2 aLaboratory of Structural Neurobiology, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; bScience for Life Laboratory, Stockholm and Uppsala, SE-17121 Stockholm, Sweden; cTheoretical and Computational Biophysics, Department of Theoretical Physics, Kungliga Tekniska Högskolan Royal Institute of Technology, SE-17121 Stockholm, Sweden; dLaboratory of Toxicology and Pharmacology, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; and eDepartment of Biochemistry and Biophysics, Center for Biomembrane Research, Stockholm University, SE-17121 Stockholm, Sweden Edited by Jean-Pierre Changeux, CNRS, Institut Pasteur, Paris, France, and approved August 22, 2016 (received for review February 24, 2016) Pentameric ligand-gated ion channels or Cys-loop receptors are insight into the mechanism of Cys-loop receptor function derives responsible for fast inhibitory or excitatory synaptic transmission. from cryo-EM images of the Torpedo marmorata nAChR (19–22) The antipsychotic compound chlorpromazine is a widely used as well X-ray crystal structures of the acetylcholine binding protein tool to probe the ion channel pore of the nicotinic acetylcholine (AChBP) (23, 24). AChBPs are water-soluble homologs of the receptor, which is a prototypical Cys-loop receptor. In this study, extracellular ligand-binding domain of the nAChR and lack the we determine the molecular determinants of chlorpromazine pore-forming transmembrane domain. To date, more than 100 binding in the Erwinia ligand-gated ion channel (ELIC). We report cocrystal structures of AChBP in complex with different agonists, the X-ray crystal structures of ELIC in complex with chlorpromazine partial agonists, antagonists, and allosteric modulators have been or its brominated derivative bromopromazine. Unexpectedly, we determined, creating a wealth of information on the molecular do not find a chlorpromazine molecule in the channel pore of ELIC, determinants of ligand recognition in nAChRs (25). Subsequently, but behind the β8–β9 loop in the extracellular ligand-binding do- the identification of Cys-loop receptors in prokaryotes (26) main. The β8–β9 loop is localized downstream from the neurotrans- PHARMACOLOGY allowed the first X-ray structure determination of integral Cys- mitter binding site and plays an important role in coupling of ligand Erwinia binding to channel opening. In combination with electrophysiolog- loop receptors ligand-gated ion channel (ELIC) (27) and ical recordings from ELIC cysteine mutants and a thiol-reactive de- Gloeobacter ligand-gated ion channel (GLIC) (28, 29), which likely rivative of chlorpromazine, we demonstrate that chlorpromazine represent a nonconducting and conducting conformation of the binding at the β8–β9 loop is responsible for receptor inhibition. channel pore, respectively. Later on, X-ray crystal structures were We further use molecular-dynamics simulations to support the determined for the first eukaryote Cys-loop receptors, including X-ray data and mutagenesis experiments. Together, these data the Caenorhabditis elegans glutamate-gated chloride channel GluCl β unveil an allosteric binding site in the extracellular ligand-bind- (30, 31), the human 3GABAAR (32), and the mouse 5-HT3AR ing domain of ELIC. Our results extend on previous observations and further substantiate our understanding of a multisite model Significance for allosteric modulation of Cys-loop receptors. Cys-loop receptors belong to a family of ion channels that are ligand-gated ion channel | X-ray crystallography | allosteric modulation | involved in fast synaptic transmission. Allosteric modulators of Cys-loop receptor | nicotinic acetylcholine receptor Cys-loop receptors hold therapeutic potential as they tweak receptor function while preserving the normal fluctuations hlorpromazine (CPZ) (Fig. 1), a phenothiazine-derived an- in neurotransmitter signaling at the synapse. Here, we take Ctipsychotic drug, was introduced in psychiatry in the early advantage of a model Cys-loop receptor, the Erwinia ligand- 1950s, revolutionizing the treatment of psychotic disorders (1, 2). gated ion channel (ELIC). We determined cocrystal structures The main mechanism of action of CPZ consists in the blockage of ELIC in complex with chlorpromazine (IC50, ∼160 μM) and of dopamine receptors (2–4), but the numerous side effects as- its brominated derivative bromopromazine, which unveil an sociated with this drug indicate that it interacts with other phys- allosteric binding site localized at the interface between the iologically relevant targets. CPZ was indeed shown to interfere extracellular ligand-binding domain and the pore-forming with several voltage- and ligand-gated channels: it inhibits neu- transmembrane domain. Our results demonstrate that the + ronal voltage-gated K channels (5–7), BKCa channels (8), and different allosteric binding sites present in Cys-loop receptors 2+ the human α1E subunit-mediated Ca channels (9); CPZ was form an almost continuous path stretching from top to bottom also shown to inhibit GABAergic currents (10, 11), specifically of the receptor. through GABAA receptors (GABAARs) (12), and to inhibit se- Author contributions: C.U. designed research; E.W., A.F., Ö.Y., M.A., M.B., R.S., S.P., and C.U. rotonin type-3 receptors (5-HT3Rs) (13, 14) and nicotinic ace- tylcholine receptors (nAChRs) (15, 16), members of the Cys-loop performed research; M.N., E.W., A.F., Ö.Y., M.A., M.B., R.S., S.P., J.T., E.L., and C.U. analyzed data; and M.N., E.W., A.F., Ö.Y., M.A., M.B., J.T., E.L., and C.U. wrote the paper. receptor family. The Cys-loop receptor family is composed of membrane- The authors declare no conflict of interest. spanning ligand-gated ion channels that are responsible for fast This article is a PNAS Direct Submission. excitatory or inhibitory synaptic neurotransmission. They are Freely available online through the PNAS open access option. composed of five identical or nonidentical subunits, each of them Data deposition: The atomic coordinates and structure factors have been deposited in the Protein Data Bank, www.pdb.org [PDB ID codes 5LG3 (ELIC+CPZ) and 5LID (ELIC+BrPZ)]. comprising an N-terminal extracellular domain, which contains 1Present address: Structural Virology, Central European Institute of Technology, Masaryk the neurotransmitter binding site, four transmembrane helices, University, 62500 Brno, Czech Republic. that when assembled allow ions to pass through the membrane, 2To whom correspondence should be addressed. Email: [email protected]. and an intracellular domain, responsible for channel conductance, This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. receptor modulation, and trafficking (17, 18). Initial structural 1073/pnas.1603101113/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1603101113 PNAS Early Edition | 1of8 Downloaded by guest on October 6, 2021 tures of ELIC in complex with CPZ or BrPZ at 3.7 Å resolution. We further characterize this interaction using two-electrode voltage- clamp (TEVC) recordings with a thiol-reactive methanethiosulfo- nate analog of CPZ (MTS-PZ) (Fig. 1C) on ELIC expressed in Xenopus oocytes and also perform molecular-dynamics simula- tions of the complex. Together, our results expand our current understanding of allosteric modulation in the family of pen- tameric ligand-gated ion channels. Results X-Ray Crystal Structures of ELIC in Complex with CPZ or BrPZ. In agreement with previous observations (43), we determined that CPZ inhibits ELIC expressed in Xenopus oocytes with an IC50 value of 158 ± 37 μM and a Hill coefficient of 1.6 ± 0.5 (n = 3– 13; Fig. 1 D and E). To investigate the structural determinants of CPZ recognition in ELIC, we determined the X-ray cocrystal structures of ELIC in complex with CPZ or BrPZ (crystallo- graphic statistics are reported in Table S1). We obtained dif- fraction data to a resolution of 3.7 Å and took advantage of the bromine atom in BrPZ to collect anomalous diffraction data, – which allowed us to calculate a so-called anomalous difference Fig. 1. Structure and function of chlorpromazine (CPZ) and analogs. (A C) density map and identify the density of the anomalously scat- Chemical structures of CPZ, bromopromazine (BrPZ), and methanethiosul- fonate-promazine (MTS-PZ), respectively. (D) Electrophysiological recordings tering electrons around the bromine atoms even at medium from Xenopus oocytes expressing ELIC. Channels were activated by the ap- resolution. Both the fivefold averaged simple electron difference plication of the agonist GABA at the EC50 (20 mM). In the presence of 30 μM density maps (Fo-Fc) as well as the fivefold averaged anomalous CPZ, this response was reduced. (E) Concentration–inhibition curve for CPZ difference density map allowed us to localize two distinct loca- on ELIC. Averaged data ± SEM are shown for three to nine different oocytes. tions for the binding of CPZ or BrPZ (Fig. 2). Unexpectedly, we do not observe any electron density in the pore domain of the channel. Instead, we observe simple difference density in the α (33). More recently, the cryo-EM structure of the 1GlyRwas extracellular ligand binding domain of ELIC at a site that is lo- determined in closed,
Recommended publications
  • Ion Channels
    UC Davis UC Davis Previously Published Works Title THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Permalink https://escholarship.org/uc/item/1442g5hg Journal British journal of pharmacology, 176 Suppl 1(S1) ISSN 0007-1188 Authors Alexander, Stephen PH Mathie, Alistair Peters, John A et al. Publication Date 2019-12-01 DOI 10.1111/bph.14749 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels. British Journal of Pharmacology (2019) 176, S142–S228 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels Stephen PH Alexander1 , Alistair Mathie2 ,JohnAPeters3 , Emma L Veale2 , Jörg Striessnig4 , Eamonn Kelly5, Jane F Armstrong6 , Elena Faccenda6 ,SimonDHarding6 ,AdamJPawson6 , Joanna L Sharman6 , Christopher Southan6 , Jamie A Davies6 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 3Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 4Pharmacology and Toxicology, Institute of Pharmacy, University of Innsbruck, A-6020 Innsbruck, Austria 5School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 6Centre for Discovery Brain Science, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties.
    [Show full text]
  • Lipid Sensitivity of a Prokaryotic Plgic 1 Structural Sensitivity of a Prokaryotic Pentameric Ligand-Gated Ion Channel To
    JBC Papers in Press. Published on March 5, 2013 as Manuscript M113.458133 The latest version is at http://www.jbc.org/cgi/doi/10.1074/jbc.M113.458133 Lipid sensitivity of a prokaryotic pLGIC Structural sensitivity of a prokaryotic pentameric ligand-gated ion channel to its membrane environment* Jonathan M. Labriola1, Akash Pandhare2, Michaela Jansen3, Michael P. Blanton2, Pierre-Jean Corringer4, and John E. Baenziger1 1From the Department of Biochemistry, Microbiology, and Immunology University of Ottawa, Ottawa ON, K1H 8M5, Canada 2Department of Pharmacology and Neuroscience and the Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430 3Department of Cell Physiology and Molecular Biophysics and the Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX. 79430. Downloaded from 4G5 Group of Channel-Receptors, CNRS URA 2182 Pasteur Institute, F75015, Paris, France *Running title: Lipid sensitivity of a prokaryotic pLGIC www.jbc.org 1To whom correspondence should be addressed: John E. Baenziger, Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, 451 Smyth Rd. Ottawa, ON, K1H 8M5, Canada, Tel.: (613) 562-5800 x8222; Fax.: (613) 562-5440; E-mail: [email protected]. at TTU-HEALTH SCIENCES CTR, on March 5, 2013 Keywords: prokaryotic pentameric ligand-gated ion channels, membrane sensitivity, structure, function _____________________________________________________________________________________ Background: The lipid sensitivity of the expression, and amenability to prokaryotic pentameric ligand-gated ion channel crystallographic analysis. We show here that (pLGIC), GLIC, is poorly characterized. membrane-reconstituted GLIC exhibits structural and biophysical properties similar Results: GLIC is more thermally stable and to those of the membrane-reconstituted does not exhibit the same propensity to adopt an nAChR, although GLIC is substantially more uncoupled conformation as the Torpedo nAChR.
    [Show full text]
  • Ligand-Gated Ion Channels
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels. British Journal of Pharmacology (2015) 172, 5870–5903 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Ligand-gated ion channels Stephen PH Alexander1, John A Peters2, Eamonn Kelly3, Neil Marrion3, Helen E Benson4, Elena Faccenda4, Adam J Pawson4, Joanna L Sharman4, Christopher Southan4, Jamie A Davies4 and CGTP Collaborators L 1 School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, N 2Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/ doi/10.1111/bph.13350/full. Ligand-gated ion channels are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage- gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The Concise Guide is published in landscape format in order to facilitate comparison of related targets.
    [Show full text]
  • Elucidating the Gating Mechanism of Cys-Loop Receptors
    Elucidating the Gating Mechanism of Cys-Loop Receptors ÖZGE YOLUK Doctoral Thesis Stockholm, Sweden 2016 TRITA FYS 2016-26 ISSN 0280-316X KTH School of Engineering Sciences ISRN KTH/FYS/–16:26–SE SE-100 44 Stockholm ISBN 978-91-7729-009-4 SWEDEN Akademisk avhandling som med tillstånd av Kungl Tekniska högskolan framlägges till offentlig granskning för avläggande av teknologie doktorsexamen i biologisk fysik måndagen den 13 juni 2016 klockan 14.00 i F3, Lindstedtsvägen 26, KTH Campus, Kungl Tekniska högskolan, Stockholm. © Özge Yoluk, June 2016 Tryck: Universitetsservice US-AB iii Abstract Cys-loop receptors are membrane proteins that are key players for the fast synaptic neurotransmission. Their ion transport initiates new nerve signals after activation by small agonist molecules, but this function is also highly sensitive to allosteric modulation by a number of compounds such as anes- thetics, alcohol or anti-parasitic agents. For a long time, these modulators were believed to act primarily on the membrane, but the availability of high- resolution structures has made it possible to identify several binding sites in the transmembrane domains of the ion channels. It is known that lig- and binding in the extracellular domain causes a conformational earthquake that interacts with the transmembrane domain (and the allosteric modula- tor sites), which leads to channel opening. The investigations carried out in this thesis aim at understanding the connection between ligand binding and channel opening with molecular modeling and computer simulations. I present new models of the mammalian GABAA receptor based on the eukaryotic structure GluCl co-crystallized with an anti-parasitic agent, and show how these models can be used to study receptor-modulator interactions.
    [Show full text]
  • Hydrocarbon Molar Water Solubility Predicts NMDA Vs. GABAA Receptor Modulation Robert J Brosnan* and Trung L Pham
    Brosnan and Pham BMC Pharmacology and Toxicology 2014, 15:62 http://www.biomedcentral.com/2050-6511/15/62 RESEARCH ARTICLE Open Access Hydrocarbon molar water solubility predicts NMDA vs. GABAA receptor modulation Robert J Brosnan* and Trung L Pham Abstract Background: Many anesthetics modulate 3-transmembrane (such as NMDA) and 4-transmembrane (such as GABAA) receptors. Clinical and experimental anesthetics exhibiting receptor family specificity often have low water solubility. We hypothesized that the molar water solubility of a hydrocarbon could be used to predict receptor modulation in vitro. Methods: GABAA (α1β2γ2s) or NMDA (NR1/NR2A) receptors were expressed in oocytes and studied using standard two-electrode voltage clamp techniques. Hydrocarbons from 14 different organic functional groups were studied at saturated concentrations, and compounds within each group differed only by the carbon number at the ω-position or within a saturated ring. An effect on GABAA or NMDA receptors was defined as a 10% or greater reversible current change from baseline that was statistically different from zero. Results: Hydrocarbon moieties potentiated GABAA and inhibited NMDA receptor currents with at least some members from each functional group modulating both receptor types. A water solubility cut-off for NMDA receptors occurred at 1.1 mM with a 95% CI = 0.45 to 2.8 mM. NMDA receptor cut-off effects were not well correlated with hydrocarbon chain length or molecular volume. No cut-off was observed for GABAA receptors within the solubility range of hydrocarbons studied. Conclusions: Hydrocarbon modulation of NMDA receptor function exhibits a molar water solubility cut-off. Differences between unrelated receptor cut-off values suggest that the number, affinity, or efficacy of protein- hydrocarbon interactions at these sites likely differ.
    [Show full text]
  • Are Nicotinic Acetylcholine Receptors Coupled to G Proteins?
    Insights & Perspectives Hypotheses Are nicotinic acetylcholine receptors coupled to G proteins? Nadine Kabbani1)*, Jacob C. Nordman1), Brian A. Corgiat1), Daniel P. Veltri2), Amarda Shehu2), Victoria A. Seymour3) and David J. Adams3) It was, until recently, accepted that the two classes of acetylcholine (ACh) synaptic plasticity [2, 3]. Mutations receptors are distinct in an important sense: muscarinic ACh receptors within nAChR genes are implicated signal via heterotrimeric GTP binding proteins (G proteins), whereas in a number of human disorders þ 2þ þ including drug addiction and schizo- nicotinic ACh receptors (nAChRs) open to allow flux of Na ,Ca ,andK phrenia [4]. ions into the cell after activation. Here we present evidence of direct coupling Nicotinic receptors belong to an between G proteins and nAChRs in neurons. Based on proteomic, evolutionarily conserved class of cys- biophysical, and functional evidence, we hypothesize that binding to G loop containing receptor channels that proteins modulates the activity and signaling of nAChRs in cells. It is includes GABAA,glycine,and5HT3 important to note that while this hypothesis is new for the nAChR, it is receptorsaswellastwonewlydiscovered channels: a zinc-activated channel and consistent with known interactions between G proteins and structurally an invertebrate GABA-gated cation chan- related ligand-gated ion channels. Therefore, it underscores an evolution- nel [5]. In mammals, genes encoding arily conserved metabotropic mechanism of G protein signaling via nAChR neuronal nAChR subunits have been channels. identified and labeled a (a1–a10) and b (b1–b4). Functional nAChRs are derived Keywords: from an arrangement of five subunits into .acetylcholine; G protein coupling; intracellular loop; ligand-gated ion channel; heteromeric or homomeric receptors [6] loop modeling; protein interaction; signal transduction (Fig.
    [Show full text]
  • Direct Visualization of Ion-Channel Gating in a Native Environment COMMENTARY Yvonne Gicherua and Sudha Chakrapania,1
    COMMENTARY Direct visualization of ion-channel gating in a native environment COMMENTARY Yvonne Gicherua and Sudha Chakrapania,1 Pentameric ligand-gated ion channels (pLGICs), also Impact of Membrane Environment on Channel known as Cys-loop receptors, are localized primarily in Gating and Dynamics the postsynaptic membranes, and mediate fast chem- Interestingly, high-resolution pLGIC structures solved ical transmission in the central and peripheral nervous thus far are in nonnative (detergent) environments, systems. Binding of neurotransmitter activates these leading to speculations on the possible alteration of receptors, causing changes in postsynaptic membrane channel structures in the absence of membranes. Mem- potential and consequently modulation of neuronal or brane composition has been shown to be critical for muscle activity. pLGIC functions are altered by a vari- channel gating of the nAChR (5) and possibly other ety of drugs, making them significant pharmaceutical eukaryotic channels. GLIC has served as an archetypal targets. Indeed, the rise in pLGIC crystal and cryoelec- pLGIC because of the overall conservation of its archi- tron microscopy structures underscores the magnitude tecture and pharmacological properties (6). GLIC crystal of research efforts that have gone into unraveling the structuresintheopenandresting conformations were molecular details of channel function. Current structure the first high-resolution pLGIC structures available (7–9). determination methods of pLGICs capture stationary Importantly, the global concerted movements resulting images and, most often, in nonnative environments. in opening of the channel pore in GLIC are comparable As a result, gaps remain in our understanding of the to the gating mechanism emerging from recent eukary- dynamic properties, intermediate conformational otic pLGIC structures.
    [Show full text]
  • Anesthetic Binding in a Pentameric Ligand-Gated Ion Channel: GLIC
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biophysical Journal Volume 99 September 2010 1801–1809 1801 Anesthetic Binding in a Pentameric Ligand-Gated Ion Channel: GLIC Qiang Chen,†6 Mary Hongying Cheng,‡6 Yan Xu,†§{ and Pei Tang†§k* † ‡ § { k Departments of Anesthesiology, Chemistry, Pharmacology and Chemical Biology, Structural Biology, and Computational Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania ABSTRACT Cys-loop receptors are molecular targets of general anesthetics, but the knowledge of anesthetic binding to these proteins remains limited. Here we investigate anesthetic binding to the bacterial Gloeobacter violaceus pentameric ligand-gated ion channel (GLIC), a structural homolog of cys-loop receptors, using an experimental and computational hybrid approach. Tryp- tophan fluorescence quenching experiments showed halothane and thiopental binding at three tryptophan-associated sites in the extracellular (EC) domain, transmembrane (TM) domain, and EC-TM interface of GLIC. An additional binding site at the EC-TM interface was predicted by docking analysis and validated by quenching experiments on the N200W GLIC mutant. The binding affinities (KD) of 2.3 5 0.1 mM and 0.10 5 0.01 mM were derived from the fluorescence quenching data of halo- thane and thiopental, respectively. Docking these anesthetics to the original GLIC crystal structure and the structures relaxed by molecular dynamics simulations revealed intrasubunit sites for most halothane binding and intersubunit sites for thiopental binding. Tryptophans were within reach of both intra- and intersubunit binding sites. Multiple molecular dynamics simulations on GLIC in the presence of halothane at different sites suggested that anesthetic binding at the EC-TM interface disrupted the critical interactions for channel gating, altered motion of the TM23 linker, and destabilized the open-channel conformation that can lead to inhibition of GLIC channel current.
    [Show full text]
  • Dynamic Closed States of a Ligand-Gated Ion Channel Captured by Cryo-EM and Simulations
    Published Online: 1 July, 2021 | Supp Info: http://doi.org/10.26508/lsa.202101011 Downloaded from life-science-alliance.org on 27 September, 2021 Research Article Dynamic closed states of a ligand-gated ion channel captured by cryo-EM and simulations Urskaˇ Rovsnikˇ 1, Yuxuan Zhuang1,Bjorn¨ O Forsberg1,2, Marta Carroni1, Linnea Yvonnesdotter1, Rebecca J Howard1 , Erik Lindahl1,3 Ligand-gated ion channels are critical mediators of electro- between principal and complementary subunits. The transmem- chemical signal transduction across evolution. Biophysical and brane domain (TMD) contains α-helices M1–M4, with M2 lining the pharmacological characterization of these receptor proteins relies channel pore, and an intracellular domain of varying length (2–80 on high-quality structures in multiple, subtly distinct functional residues) inserted between M3 and M4. Extracellular agonist states. However, structural data in this family remain limited, binding is thought to favor subtle structural transitions from resting particularly for resting and intermediate states on the activation to intermediate or “flip” states (2), opening of a transmembrane pathway. Here, we report cryo-electron microscopy (cryo-EM) pore (5), and in most cases, a refractory desensitized phase (6). structures of the proton-activated Gloeobacter violaceus ligand- Accordingly, a detailed understanding of pentameric channel gated ion channel (GLIC) under three pH conditions. Decreased pH biophysics and pharmacology depends on high-quality structural was associated with improved resolution and side chain rear- templates in multiple functional states. However, high-resolution rangements at the subunit/domain interface, particularly involving structures can be biased by stabilizing measures such as ligands, functionally important residues in the β1–β2andM2–M3 loops.
    [Show full text]
  • Mechanisms of Nmda Receptor Inhibition by Memantine and Ketamine
    MECHANISMS OF NMDA RECEPTOR INHIBITION BY MEMANTINE AND KETAMINE by Nathan G. Glasgow Bachelor of Science, University of Toledo, 2010 Submitted to the Graduate Faculty of the Kenneth P. Dietrich School of Arts and Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH DIETRICH SCHOOL OF ARTS AND SCIENCES This dissertation was presented by Nathan G. Glasgow It was defended on April 21, 2016 and approved by Dr. Stephen D. Meriney, Professor, Department of Neuroscience Dr. Anne-Marie Oswald, Assistant Professor, Department of Neuroscience Dr. Elias Aizenman, Professor, Department of Neurobiology Dr. Michael S. Gold, Professor, Department of Anesthesiology Dr. Stephen F. Traynelis, Professor, Department of Pharmacology, Emory University Dissertation Advisor: Dr. Jon W. Johnson, Professor, Department of Neuroscience ii Copyright © by Nathan G. Glasgow 2016 iii MECHANISMS OF NMDA RECEPTOR INHIBITION BY MEMANTINE AND KETAMINE Nathan G. Glasgow, PhD University of Pittsburgh, 2016 NMDA receptors (NMDARs), a subfamily of ionotropic glutamate receptors, have unique biophysical properties including high permeability to Ca2+. Activation of NMDARs increases the concentration of intracellular Ca2+ that can activate a vast array of signaling pathways. NMDARs are necessary for many processes including synaptic plasticity, dendritic integration, and cell survival. Aberrant NMDAR activation is implicated in many central nervous system disorders including neurodegenerative disorders, neuronal loss following ischemia, and neuropsychiatric disorders. Hope that NMDARs may serve as useful therapeutic targets is bolstered by the clinical success of two NMDAR antagonists, memantine and ketamine. Memantine and ketamine act as open channel blockers of the NMDAR-associated ion channel, and exhibit similar IC50 values and kinetics.
    [Show full text]
  • Multiple Binding Sites for the General Anesthetic Isoflurane Identified in the Nicotinic Acetylcholine Receptor Transmembrane Domain
    Multiple binding sites for the general anesthetic isoflurane identified in the nicotinic acetylcholine receptor transmembrane domain Grace Brannigana,1, David N. LeBarda, Jérôme Héninb, Roderic G. Eckenhoffc, and Michael L. Kleina,1 aInstitute for Computational and Molecular Science, Temple University, Philadelphia, PA 19122; bLaboratoire d’Ingénierie des Systèmes Macromoléculaires, Centre National de la Recherche Scientifique—Aix-Marseille Université, 13402 Marseille, France; and cDepartment of Anesthesiology and Critical Care, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Contributed by Michael L. Klein, June 24, 2010 (sent for review May 12, 2010) An extensive search for isoflurane binding sites in the nicotinic An intriguing difference between the nAChR structure acetylcholine receptor (nAChR) and the proton gated ion channel reported in 2BG9 and the prokaryotic structures are the large from Gloebacter violaceus (GLIC) has been carried out based on mo- gaps in protein density in the extracellular half of the nAChR lecular dynamics (MD) simulations in fully hydrated lipid membrane transmembrane domain (TMD). The high-resolution prokaryotic environments. Isoflurane introduced into the aqueous phase readily structures do not display such gaps (Fig. S1). Recently (14), we partitions into the lipid membrane and the membrane-bound pro- proposed that such gaps are occupied by cholesterol, which is tein. Specifically, isoflurane binds persistently to three classes of essential for nAChR function (15). Because cholesterol is not sites in the nAChR transmembrane domain: (i) An isoflurane dimer found in prokaryotic membranes, this hypothesis provides an occludes the pore, contacting residues identified by previous muta- alternate explanation to the source of differences between the genesis studies; analogous behavior is observed in GLIC.
    [Show full text]
  • Polish Neuroscience Society (PTBUN)
    ORGANIZATION Organizer: Polish Neuroscience Society (PTBUN) Co-organizers: Department for Experimental Medicine, Medical University of Silesia in Katowice Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw Institute of Pharmacology, Polish Academy of Sciences, Kraków International Institute of Molecular and Cell Biology, Warsaw SCIENTIFIC PROGRAM COMMITTEE Chairmen: Members: Jan Celichowski Agata Adamczyk Grzegorz Hess Vice-Chairmen: Ewa Kublik Jarosław J. Barski Monika Liguz-Lęcznar Jacek Jaworski Jan Rodriguez Parkitna Małgorzata Skup LOCAL ORGANIZING COMMITTEE Chairmen: Members: Jarosław J. Barski Dominika Chojnacka Aniela Grajoszek Vice-Chairmen: Daniela Kasprowska-Liśkiewicz Marta Nowacka-Chmielewska Arkadiusz Liśkiewicz Marta Przybyła Anna Sługocka Acta Neurobiol Exp 2019_79_supp_inner_v4.indd 1 17/08/2019 22:16 II 14th International Congress of the Polish Neuroscience Society Acta Neurobiol Exp 2019, 79: I–XCIX HONORARY PATRONATE The Mayor of Katowice Rector of Medical Katowice City City University of Silesia SPONSORS AND FINANCIAL SUPPORT Ministry of Science and Higher Education Polish Academy of Sciences Katowice City Vivari s.c. Noldus Information Technology European Brain and Behavior Society CED MMM Muenchener Medizin Mechanik Polska Sp. z o.o. OMIXYS Sp. z o.o. Science Products GmbH SHIM-POL A.M. Borzymowski Femtonics Acta Neurobiol Exp 2019_79_supp_inner_v4.indd 2 17/08/2019 22:16 Acta Neurobiol Exp 2019, 79: I–XCIX Programme III PROGRAMME 27.08.2019, TUESDAY 12:00–14:00 Workshop on Ultrasonic Vocalization (USV) ‑ theory 14:00–15:00 Lunch 15:00–18:00 Workshop on Ultrasonic Vocalization (USV) ‑ practice 28.08.2019, WEDNESDAY 12:00–14:30 General Assembly of PTBUN 14:30–15:00 Opening Ceremony 15:00–16:00 Plenary lecture 1 (PL 1) Speaker: Magdalena Götz, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany Title: “Novel mechanisms of neurogenesis and neural repair” Introduced by: Jarosław J.
    [Show full text]